论文部分内容阅读
目的探讨宝乐安联用促肝细胞生长素在治疗小儿肝功损害的作用。方法将不同病因引起的120例转氨酶增高患儿随机分为促肝细胞生长素组(对照组)和宝乐安联用促肝细胞生长素组(治疗组)两组。结果治疗组降低ALT、AST的作用与对照组比较,差异有统计学意义(P<0.01)。结论宝乐安联用促肝细胞生长素对小儿肝功损害疗效显著,且明显缩短疗程。
Objective To investigate the effect of baoanan combined with hepatocyte growth-promoting factor in the treatment of liver damage in children. Methods A total of 120 children with elevated aminotransferase induced by different etiology were randomly divided into two groups: the hepatocyte growth-promoting factor group (control group) and Baoluan combined hepatocyte growth-promoting factor group (treatment group). Results Compared with the control group, the effect of reducing ALT and AST in the treatment group was statistically significant (P <0.01). Conclusion Bailean combined with hepatocyte growth promoting hormone in children with significant effect of liver damage, and significantly shorten the course of treatment.